Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 0.4.

  • Autolus Therapeutics' Equity Ratio fell 3042.73% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year decrease of 3042.73%. This contributed to the annual value of 0.55 for FY2024, which is 8384.33% up from last year.
  • Latest data reveals that Autolus Therapeutics reported Equity Ratio of 0.4 as of Q3 2025, which was down 3042.73% from 0.48 recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Equity Ratio registered a high of 0.77 during Q4 2021, and its lowest value of 0.3 during Q4 2023.
  • Over the past 5 years, Autolus Therapeutics' median Equity Ratio value was 0.58 (recorded in 2023), while the average stood at 0.56.
  • As far as peak fluctuations go, Autolus Therapeutics' Equity Ratio plummeted by 5125.36% in 2023, and later soared by 8384.33% in 2024.
  • Over the past 5 years, Autolus Therapeutics' Equity Ratio (Quarter) stood at 0.77 in 2021, then fell by 21.15% to 0.61 in 2022, then crashed by 51.25% to 0.3 in 2023, then skyrocketed by 83.84% to 0.55 in 2024, then fell by 26.55% to 0.4 in 2025.
  • Its Equity Ratio was 0.4 in Q3 2025, compared to 0.48 in Q2 2025 and 0.5 in Q1 2025.